The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRCHA.L Regulatory News (RCHA)

  • There is currently no data for RCHA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

23 Sep 2019 15:08

RNS Number : 3399N
Rothschild & Co Contin Fin CI Ltd
23 September 2019
 

Rothschild & Co Continuation Finance CI Limited

 

Half-yearly Report for the six-month period ended 30 June 2019

 

Interim Management Report

 

Summary of Important Events

 

Rothschild & Co Continuation Finance CI Limited (the "Company") is a wholly-owned subsidiary of Rothschild & Co Continuation Limited. The principal activity of the Company is the raising of finance for the purpose of lending it to companies who are members of the Rothschild Concordia SAS group. In the period ended 30 June 2019, £125,000,000 perpetual subordinated guaranteed notes were in issue by the Company.

 

Comparative numbers in the six months to 30 June 2018 have been amended to reflect the impact of IFRS 9 on accounting for financial instruments.

 

Risks and Uncertainties

 

The principal risks of the Company are credit risk, liquidity risk, market risk and operational risk. The Company follows the risk management policies of a fellow Group company, N M Rothschild & Sons Limited.

 

The Company's market risk exposure is limited to interest rate risk. Exposure to interest rate movements on the perpetual subordinated note issues has been passed to a fellow subsidiary N M Rothschild & Sons Limited ("NMR") and parent undertaking Rothschild & Co Continuation Limited ("R&CoCL"), as the issue proceeds have been on-lent to NMR and R&CoCL at a fixed margin of 1/64 per cent above the rate being paid. Currency risk is not considered significant as all material foreign currency balances and cash flows are matched.

 

Liquidity risk has similarly been transferred to NMR and R&CoCL as the funds on-lent have the same maturity dates as the notes issued.

 

The Company's principal credit risk is with NMR and R&CoCL. Since notes issued by the Company have been guaranteed by R&CoCL, and funds have been on-lent to NMR and R&CoCL, the Company's ability to meet its obligations in respect of notes issued by it is affected by NMR's and R&CoCL ability to make payments to the Company.

 

Operational risk arising from inadequate or failed internal processes, people and systems or from external events is managed by maintaining a strong framework of internal controls.

 

This half-yearly financial report has not been audited or reviewed by the Company's auditors pursuant to the Auditing Practices Board guidance on Review of Interim Financial Information.

 

 

Responsibility Statement

 

The Directors confirm that to the best of their knowledge:

 

 

-

The condensed set of financial statements has been prepared in accordance with IAS 34 Interim Financial Reporting; and

 

-

The interim management report includes a fair review of (i) the important events that have occurred during the first six months of the financial year, and their impact on the condensed set of financial statements, and (ii) the principal risks and uncertainties for the remaining six months of the financial year.

 

By Order of the Board

 

Peter Barbour

Director

 

 

 

Condensed Interim Statement of Comprehensive Income

For the six months ended 30 June 2019

 

 

 

6 months to

6 months to

 

 

30 June2019

30 June2018

 

Note

£

£

Interest income

 

5,557,577

5,557,577

Interest expense

 

(5,547,945)

(5,547,945)

Operating profit

 

9,632

9,632

Revaluation of loans

4

(525,000)

(3,750,000)

Revaluations of debt securities

9

525,000

3,750,000

Administrative expenses

 

(650)

(651)

Profit before tax

 

8,982

8,981

Income tax expense

3

(1,707)

(1,706)

Profit for the financial period

 

7,275

7,275

Other comprehensive income

 

-

-

Total comprehensive income for the financial period

 

7,275

7,275

 

Condensed Interim Statement of Changes in Equity

For the six months ended 30 June 2019

 

 

 

Share Capital

Retained Earnings

 

Total

 

£

£

£

At 1 January 2019

100,000

145,269

245,269

Total comprehensive income for the period

-

7,275

7,275

At 30 June 2019

100,000

152,544

252,544

At 31 December 2017

100,000

26,268

126,268

Transition to IFRS 9

-

103,750

103,750

At 1 January 2018

100,000

130,018

230,018

Total comprehensive income for the period

-

7,275

7,275

At 30 June 2018

100,000

137,293

237,293

 

 

Condensed Interim Balance Sheet

At 30 June 2019

 

 

 

At 30 June

At 31 December

 

 

2019

2019

2018

2018

 

Note

£

£

£

£

Non-current assets

 

 

 

 

 

Loans to group undertakings

4

 

153,662,500

 

154,187,500

Current assets

 

 

 

 

 

Other financial assets

5

4,137,254

 

6,496,137

 

Cash and cash equivalents

6

146,961

 

3,481,151

 

 

 

4,284,215

 

9,977,288

 

Current liabilities

 

 

 

 

 

Current tax payable

 

(5,284)

 

(3,577)

 

Deferred tax

7

(21,250)

 

(21,250)

 

Other financial liabilities

8

(4,130,137)

 

(9,832,192)

 

Net current assets

 

 

127,544

 

120,269

Total assets less current liabilities

 

 

 

153,790,044

 

 

154,307,769

Non-current liabilities

 

 

 

 

 

Subordinated guaranteed notes

9

 

(153,537,500)

 

(154,062,500)

Net assets

 

 

252,544

 

245,269

Shareholders' equity

 

 

 

 

 

Share capital

11

 

100,000

 

100,000

Retained earnings

 

 

152,544

 

145,269

Total shareholders' equity

 

 

252,544

 

245,269

 

 

Condensed Interim Cash Flow Statement

For the six months ended 30 June 2019

 

 

 

6 months to

6 months to

 

 

30 June 2019

30 June 2018

 

Note

£

£

Cash flow from operating activities

 

 

 

Profit for the financial period

 

7,275

7,275

Income tax expenses

 

1,707

1,706

Operating profit before changes in working capital and provisions

 

 

8,982

 

8,981

Fair value movements of loans

 

525,000

3,750,000

Fair value movements of debt securities

 

(525,000)

(3,750,000)

Net decrease in other financial assets

 

2,358,883

2,358,885

Net decrease in other financial liabilities

 

(5,702,055)

(5,702,055)

Cash (utilised)/generated from operations

 

(3,334,190)

(3,334,189)

Net cash (used in)/from operating activities

 

(3,334,190)

(3,334,189)

Net (decrease)/increase in cash and cash equivalents

 

 

(3,334,190)

 

(3,334,189)

Cash and cash equivalents at beginning of period

 

3,481,151

3,465,064

Cash and cash equivalents at end of period

6

146,961

130,875

 

Interest paid and received during the period were as follows:

 

6 months to

6 months to

30 June 2019

30 June 2018

£

£

Interest paid

11,250,000

11,250,000

Interest received

7,916,460

7,916,462

 

The notes to the condensed interim financial statements form an integral part of the condensed interim financial statements.

 

 

 

Notes to the Condensed Interim Financial Statements

(forming part of the Condensed Interim Financial Statements)

For the six months ended 30 June 2019

 

1. Basis of preparation

 

The condensed interim financial statements are prepared and approved by the Directors in accordance with IAS 34 Interim Financial Reporting. The condensed interim financial statements are prepared under the historical cost accounting rules and should be read in conjunction with the annual financial statements for the year ended 31 December 2018, which have been prepared in accordance with International Financial Reporting Standards.

 

The accounting policies and methods of valuation are identical to those applied in the financial statements for the year ended 31 December 2018.

 

2. Directors' Emoluments

 

None of the Directors received any remuneration in respect of their services to the Company during the period (2018: £nil).

 

 

3. Taxation

 

6 months to

6 months to

 

30 June 2019

30 June 2018

 

£

£

Profit before tax

8,982

8,981

United Kingdom corporation tax at 19%

1,707

1,706

Tax charged for the period

1,707

1,706

 

 

 

4. Loans to Group Undertakings

 

At 30 June

At 31 December

2019

2018

£

£

At beginning of period

154,187,500

125,000,000

Revaluation due to transition to IFRS 9

-

35,125,000

154,187,500

160,125,000

Fair value movements

(525,000)

(5,937,500)

At end of period

153,662,500

154,187,500

Due

In 5 years or more

153,662,500

154,187,500

 

 

IFRS 9 requires the £125,000,000 loans to be carried at fair value which as at 30 June 2019 was £153,662,500 (at 31 December 2018: £154,187,500). On an amortised cost basis, the value of the loan at 30 June 2019 would be £125,000,000 (at 31 December 2018: £125,000,000). The fair values are based on the market value of the external debt securities (level 2).

 

The interest rate charged on the subordinated perpetual loans to group undertakings is 9 1/64 per cent.

 

 

5. Other Financial Assets

 

At 30 June

At 31 December

 

2019

2018

 

£

£

Amounts owed by parent undertaking

2,482,352

2,556,432

Amounts owed by fellow subsidiary undertaking

1,654,902

3,939,705

 

4,137,254

6,496,137

 

6. Cash and Cash Equivalents

 

At 30 June 2019 the Company held cash of £146,961 (31 December 2018: £3,481,151) to a fellow subsidiary undertaking.

 

7. Deferred Income Taxes

 

At 30 June2019

At 31 December2018

£

£

At beginning of period

(21,250)

-

Transition to IFRS 9

-

(21,250)

At end of period

(21,250)

(21,250)

 

 

Deferred tax assets less liabilities are attributable to the following items:

 

At 30 June

2019

At 31 December

2018

£

£

Fair value of intra group loans

(4,872,625)

(4,961,875)

Fair value of debt securities in issue

4,851,375

4,940,625

(21,250)

(21,250)

Both the intra-group loans and debt securities in issue are taxed on an amortised cost basis of accounting and accordingly taxable/deductible temporary differences arise following the adoption of IFRS 9.

 

 

8. Other Financial Liabilities

 

At 30 June

At 31 December

 

2019

2018

 

£

£

Interest payable

4,130,137

9,832,192

 

Interest is payable on the subordinated guaranteed notes at 9 per cent.

 

 

9. Subordinated Guaranteed Notes

At 30 June

At 30 December

2019

2018

£

£

At beginning of period

154,062,500

125,000,000

Revaluation due to transition to IFRS 9

-

35,000,000

154,062,500

160,000,000

Fair value movements

(525,000)

(5,937,500)

At end of period

153,537,500

154,062,500

Due

In 5 years or more

153,537,500

154,062,500

 

Given the IFRS 9 requirement to fair value the related loans, the Company has elected to fair value the subordinated guaranteed notes, which as at 30 June 2019 was £153,537,500 (at 31 December 2018: £154,062,500). On an amortised cost basis, the value of the subordinated guaranteed notes at 30 June 2019 would be £125,000,000 (at 31 December 2018: £125,000,000). The fair value was derived from the quoted market price at the balance sheet date (level 1).

 

 

10. Maturity of Financial Liabilities

 

The following table shows contractual cash flows payable by the Company on the subordinated guaranteed notes, analysed by remaining contractual maturity at the balance sheet date. Interest cash flows on the loan notes are shown up to five years only, with the principal balance being shown in the > 5yr column.

 

 

Demand

Demand - 3m

3m - 1yr

1yr - 5yr

>5 yr

Total

 

£

£

£

£

£

£

Loan notes in issue

-

 -

11,250,000

45,000,000

125,000,000

181,250,000

 

11. Share Capital

 

At 30 June

At 31 December

 

2019

2018

 

£

£

Authorised

 

 

Ordinary shares of £1 each

100,000

100,000

Allotted, called up and fully paid

 

 

Ordinary shares of £1 each

100,000

100,000

 

12. Related Party Transactions

 

Parties are considered to be related if one party controls, is controlled by or has the ability to exercise significant influence over the other party. This includes key management personnel, the parent company and fellow subsidiaries.

 

Amounts recognised in respect of related parties at the period end were as follows:

 At 30 June

2019

At 31 December

2018

£

£

Subordinated perpetual loan to parent undertaking - fair value

61,465,000

61,675,000

Subordinated perpetual loan to fellow subsidiary undertaking - fair value

92,197,500

92,512,500

Amounts owed by parent undertaking

2,482,352

2,556,432

Amounts owed by fellow subsidiary undertaking

1,654,902

3,939,705

Cash at fellow subsidiary undertaking

146,961

3,481,151

Amounts recognised in the statement of comprehensive income in respect of related party transactions were as follows:

6 months to

30 June

2019

6 months to

30 June2018

£

£

Interest receivable from parent undertaking

3,334,546

3,334,546

Interest receivable from fellow subsidiary undertaking

2,223,031

2,223,031

There were no loans made to Directors during the period (6 months to 30 June 2018: none) and no balances outstanding at the period end (at 31 December 2018: £nil). There were no employees of the Company during the period (6 months to 30 June 2018: none).

13. Parent Undertaking and Ultimate Holding Company and Registered Office

The largest group in which the results of the Company are consolidated is that headed by Rothschild & Co Concordia SAS, incorporated in France. The smallest group in which they are consolidated is that headed by Rothschild & Co SCA, a French public limited partnership, whose registered office is also at 23bis, Avenue de Messine, 75008 Paris. The accounts are available on the Rothschild & Co website at www.rothschildandco.com.

The Company's immediate parent company is Rothschild & Co Continuation Limited, incorporated in England and Wales and whose registered office is at New Court, St Swithins Lane, London EC4N 8AL.

The Company's registered office is located at St Julian's Court, St Peter Port, Guernsey, GY1 3BP.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR ZXLFLKKFBBBX
Date   Source Headline
4th Jan 20247:30 amRNSNotice of Optional Redemption
4th Sep 20236:29 pmRNSHalf-year Report ended 30 June 2023
27th Apr 20236:47 pmRNSAnnual Financial Report
13th Sep 20224:23 pmRNSHalf-year Report
29th Apr 20225:41 pmRNSAnnual Financial Report
20th Sep 20215:28 pmRNSHalf-year Report
28th Apr 20214:47 pmRNSAnnual Financial Report
27th Apr 20215:55 pmRNSFinal Results
22nd Sep 20207:00 amRNSHalf-year Report
1st May 20205:08 pmRNSAnnual Financial Report
29th Apr 20205:47 pmRNSAnnual Financial Report
23rd Sep 20193:08 pmRNSHalf-year Report
13th May 20194:43 pmRNSPublication of Annual Financial Report
30th Apr 20195:38 pmRNSFinal Results
2nd Nov 201811:30 amRNSChange of Name
2nd Nov 201811:20 amRNSChange of Name
21st Sep 20183:54 pmRNSHalf-year Report
13th Apr 20184:02 pmRNSAnnual Financial Report
29th Mar 20187:00 amRNSAnnual Financial Report
30th Nov 20174:10 pmRNSHalf-year Report
13th Jul 201712:58 pmRNSAnnouncement of Annual Financial Report
30th Jun 201710:53 amRNSAnnual Financial Report
12th Dec 20164:10 pmRNSHalf-year Report
20th Jul 20163:21 pmRNSAnnouncement of Annual Financial Report
14th Jul 201611:43 amRNSAnnual Financial Report
13th Apr 20165:00 pmRNSSimplification of deposit taking activities
26th Nov 20155:34 pmRNSHalf Yearly Report
2nd Oct 20157:00 amRNSSale of Rothschild & Co's Asset Finance Business
21st Jul 20154:52 pmRNSAvailability of Annual Financial Report
21st Jul 20154:02 pmRNSFinal Results
28th Nov 20149:38 amRNSHalf Yearly Report
31st Jul 201411:11 amRNSDoc re. Availability of Annual Financial Report
31st Jul 201411:11 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.